Showing posts with label diagnostics. Show all posts
Showing posts with label diagnostics. Show all posts

Tuesday, 14 July 2020

San Francisco-Based Startup Vivoo Wants to Make Urinalysis as Easy as a Pregnancy Test


San Francisco-based startup Vivoo has developed an innovative wellness assistant right on your phone that can give you personalized nutrition advice based on a urinalysis strip as simple to use as a home pregnancy test.

Simply pee on the stick on several exposed strips that will then test for a number of wellness and healthcare factors. Depending on the contents of your urine, the color of the strips will change, which is where your phone comes in.

Using the Vivoo app on your phone, simply take a picture of the strip after a few minutes to give the results have had enough time to develop and based on the color of the test strips, the app will tell you whether you are drinking enough water, whether you are at risk for developing a urinary tract infection, as well as kidney and liver function among other factors.

Read on

This Startup Wants to Make Urinalysis as Easy as a Pregnancy Test

Vivoo has created a new subscription-based urinalysis app that can determine everything from whether you're drinking enough water to risk factors for a urinary tract infection, all right from your phone (and no, you don't have to pee on your phone).

Pune-based Mylab launches 'Compact XL' to automate molecular diagnostic tests for COVID-19


Pune-based molecular diagnostics company, Mylab Discovery Solutions Pvt. Ltd. has launched 'Compact XL' - India's first machine to automate the manual processes of molecular diagnostic tests such as RT-PCR tests for Covid-19. According to an official press release, Compact XL is a compact bench-top machine that will automate lab processes from sample handling to preparing RT-PCR ready tubes. The machine can take input of various sample types such as plasma, tissue, sputum and swab.

Speaking about benefits of this 100 per cent indigenously developed machine, Hasmukh Rawal, Promoter and MD, Mylab Discovery Solutions said, "Compact XL will replace the need of 700 sq ft of cleanroom lab with a 4x3 benchtop machine and reduce the need of 3-4 expert technicians to just one, saving operational costs for labs."

The machine can run 32 samples at a time which can be further increased when machines are connected in a network. Compact XL will be available for pre-ordering starting 13 July 2020.

Read on

Pune-based Mylab launches 'Compact XL' to automate molecular diagnostic tests for COVID-19

Pune (Maharashtra) [India], July 7 (ANI): Pune-based molecular diagnostics company, Mylab Discovery Solutions has launched 'Compact XL' - India's first machine to automate the manual processes of molecular diagnostic tests such as RT-PCR tests for Covid-19.According to an official press release, Compact XL is a compact bench-top machine that will automate lab processes from sample handling to preparing RT-PCR ready tubes.It is a cartridge-based machine and can test multiple samples at the same time.

Wednesday, 8 July 2020

Indian healthtech startup 5C Network is using AI and ML to speed up radiology scan results


5C Network, a Bengaluru based healthtech startup, co-founded by Kalyan Sivasailam and Syed Ahmed in 2016, reduces the turnaround time to come out with the radiology test results - in just 42 minutes, and also ensures higher degree of accuracy. 5C Network has created an #AI technology platform, bringing together all the participants such as radiologists, hospitals, and diagnostic centres.

The radiology market is highly fragmented with these services present in hospitals, diagnostic centres. and even private clinics. According to industry reports, the Indian radiology market is estimated at a size of around Rs 45,000 crore.

In 2016, 5C Network started doing 26 radiology reports a month, and has now reached an average of 80,000. It has around 350 radiologists on its platform with 600 clients across the country.

The startup has raised around Rs 5 crore in funding till now from Unitus Ventures, Axilor, and the Centre for Innovation Incubation and Entrepreneurship (CIIE), the technology business incubator of IIM Ahmedabad. It is looking to raise another round of funding soon.

Read on

This healthtech startup is using AI and ML to speed up radiology scan results

Few years ago, Syed Ahmed underwent an MRI scan and had to wait for three days to collect the radiology report. This triggered the idea for Syed and his friend, Kalyan Sivasailam, to create a digital platform for faster results.

Tuesday, 7 July 2020

Medical Technology: Rapid Diagnostics Device Developed Using Figure 4 Standalone | 3D Systems


A team of researchers at Imperial College London, led by Dr. Pantelis Georgiou, is tackling this problem head-on with a project called Lacewing for pathogen detection. Offering results within 20 minutes from a smartphone app synced to a cloud server, Lacewing makes disease testing portable, including SARD-CoV-2-RNA, and automates the tracking of disease progression through geotagging.

It is a sophisticated “lab-on-a-chip” platform that promises to fill the access- and information-gaps in the world of diagnostics by combining molecular biology and state-of-the-art technology. Whereas other diagnostics technology requires large and expensive optical equipment, the electrical sensing method and small size of Lacewing is a true evolution in approach.

The Lacewing platform is a molecular diagnostic test that works by identifying the DNA or RNA of a pathogen within a patient sample. This type of test makes it possible to determine not only if someone is infected with a certain disease (dengue, malaria, tuberculosis, COVID-19, etc.), but to what degree, which provides more insight into the severity of the symptoms.

Read on

Rapid Diagnostics Device Developed Using Figure 4 Standalone | 3D Systems

The Lacewing project out of Imperial College London is a lab-on-a-chip platform for diagnosing and tracking diseases, with key components 3D printed using 3D Systems' Figure 4 and biocompatible-capable materials.

Monday, 6 July 2020

Startups: How technology and healthcare can work together in a post-pandemic world | e27


Healthcare industry across the world has faced enormous setbacks in the past few months when the novel coronavirus affected a million lives in the most fatal manner.

As social distancing becomes the new normal, here’s how the healthcare and technology could change in a post-pandemic world.

Read on

How technology and healthcare can work together in a post-pandemic world | e27

As social distancing becomes the new normal, here’s how the healthcare and technology could change in a post-pandemic world

Saturday, 4 July 2020

Technology: Scientists develop stamp-sized, wearable device that can record body temperature and blood oxygen levels to monitor Covid-19


Researchers have developed a stamp-sized device, comprising a suite of sensors, including ones , an advance that can be used to catch early signs and symptoms of COVID-19, and help monitor patients as the illness progresses.

The scientists, including John A. Rogers from Northwestern University in the US, said they have tested the novel device on more than 50 physicians, rehabilitation specialists, and patients at the country's Shirley Ryan AbilityLab and at the Northwestern Memorial Hospital.

According to an editorial, published in the journal Science Advances, the sticker-like medical device, which is of the size of a postage stamp, is soft, flexible, and sits just below the suprasternal notch - the visible dip at the base of the throat.

"As you cough and breathe, it counts coughs, monitors the intensity of cough and senses laboured breathing. The location on the throat also is close enough to the carotid artery that it can measure mechanical signatures of blood flow, monitoring heart rate," he added.

Eventually, they believe the self-learning algorithms will become smart enough to distinguish between a COVID-like cough and more benign coughs from allergies, colds or dryness.

Read on

Scientists develop stamp-sized, wearable device that can record body temperature and blood oxygen levels to monitor Covid-19

WASHINGTON: Researchers have developed a stamp-sized device, comprising a suite of sensors, including ones , an advance that can be used to catch early signs and symptoms of COVID-19, and help monitor patients as the illness progresses. The scientists, including John A.

Wednesday, 1 July 2020

Startup Funding Alert: Berlin's DeepSpin raises seed funding for its 'portable, ultra-low-cost' MRI system


DeepSpin, a Berlin-based startup co-founded by Clemens Tepel, a former McKinsey consultant, and Pedro Freire Silva, a PhD researcher from KIT, that is developing what it describes as a “next-generation, AI-powered MRI imaging machine,” has raised €600,000 in seed funding.

Backing the round is APEX Digital Health, with participation from existing investors Entrepreneur First (EF) and SOSV, along with a number of unnamed angel investors. Including grants and earlier investments, it brings the total raised to €1 million pre-launch.

Yet-to-launch and still in the development phase, DeepSpin aims to build a new type of MRI system at a “fraction of the cost, weight and size” of existing systems. To make this possible, the startup has developed a new antenna technology combined with AI-controlled operation, which the startup is currently patenting.

It is very happy to note that they are removing all of the constraints with traditional MRI scanners, based on their proprietary technology, making MRI universally accessible for any patient, anywhere in the world.

Read on

Berlin's DeepSpin raises seed funding for its 'portable, ultra-low-cost' MRI system

DeepSpin, a Berlin-based startup that is developing what it describes as a "next-generation, AI-powered MRI imaging machine," has raised €600,000 in seed funding. Backing the round is APEX Digital Health, with participation from existing investors Entrepreneur First (EF) and SOSV, along...

Startup Funding Alert: Dutch healthtech AI startup Quantib gets €2 million for prostate cancer diagnostics - Tech.eu


Quantib, a Dutch medtech startup applying artificial intelligence to radiology, has received a €2.1 million grant from the European Innovation Council (EIC) Accelerator fund for a new diagnostic approach to prostate cancer.

The healthtech startup’s AI software helps analyse medical images so that doctors can more quickly detect and diagnose any abnormalities. The software has already been applied to other forms of cancer, and Quantib says the application to prostate cancer, specifically, could be the first of its kind in the world.

Read on

Dutch healthtech AI startup Quantib gets €2 million for prostate cancer diagnostics - Tech.eu

Quantib, a Dutch medtech startup applying artificial intelligence to radiology, has received a €2.1 million grant from the European Innovation Council (EIC) Accelerator fund for a new diagnostic approach to prostate cancer. The healthtech startup's AI software helps analyse medical images so that doctors can more quickly detect and diagnose any abnormalities.